Business Context and Reporting Period
This Form 8-K is filed by eXegenics Inc. (not OPKO Health, Inc.) for the reporting period of October 12, 2004. The registrant is a Delaware corporation headquartered in Pittsford, New York.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory status regarding stock listing.
Material Changes
- Delisting Notice: On October 12, 2004, the Company received notification from NASDAQ that its securities will be delisted effective with the open of trading on Thursday, October 14, 2004.
- OTC Eligibility: The securities are not immediately eligible to trade on the OTC Bulletin Board because the delisting was based on concerns under Nasdaq Marketplace Rule 4330.
Outlook, Risks, and Management Commentary
Management states the Company is working diligently to have its common stock trading on the OTC Bulletin Board. The primary risk identified is the immediate cessation of trading on the Nasdaq Stock Market and the potential delay in establishing trading on the OTC Bulletin Board due to the specific nature of the delisting (Rule 4330 concerns).
Investor Verification Checklist
- Verify the specific compliance issues under Nasdaq Marketplace Rule 4330 that triggered the delisting.
- Confirm the timeline for potential approval to trade on the OTC Bulletin Board.
- Check for any subsequent filings regarding the status of the OTC trading application.
- Confirm the current trading symbol and venue for the Company's stock post-delisting.